REVIEW
|
doi:10.20944/preprints201903.0133.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Pancreatic cancer; PDAC (Pancreatic Ductal Adenocarcinoma); immune microenvironment; immune biomarkers; personalized cancer care; inflammation; PD1; CTLA-4
Online: 12 March 2019 (03:15:16 CET)